Print this page 
Cancer
More than 88,000 Australians are diagnosed with cancer every year.
PHI cancer research has a strong focus on the relationships between hormones and reproductive cancers.
Research teams are working collaboratively to understand some of the key unanswered questions about why and how cancer develops, to develop early detection methods for ovarian cancer and towards new targeted treatments for breast cancers of bone.
These PHI Laboratories have a focus on cancer:
Cancer Drug Discovery is seeking to understand key biological pathways, identify new drugs and to develop new breast cancer therapies.
Metabolism & Cancer is studying how hormones, body metabolism and obesity affect the development of breast cancer.
Ovarian Cancer Biomarkers is using new techniques to develop tests which will be able to detect ovarian cancer in the earliest stages.
Bone, Joint & Cancer is leading new insights into the biology of cancer which has spread from extraskeletal sites to bone.
Reproductive Development & Cancer is studying the relationship between normal cell growth and cancer.
Steroid Receptor Biology is linking gene function to tumour biology.